{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:34:59Z","timestamp":1787427299935,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008067","name":"Genomic Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.breast.2021.08.018","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T08:34:41Z","timestamp":1630398881000},"page":"S50-S53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["Axillary surgery in node-positive breast cancer"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-0245","authenticated-orcid":false,"given":"Nadia","family":"Maggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Nussbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liezl","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2021.08.018_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.breast.2021.08.018_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial HHS public access","volume":"318","author":"Giuliano","year":"2017","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.breast.2021.08.018_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2021.08.018_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla \u2013 surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2021.08.018_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 Years or older with early breast cancer: long-term follow-up of CALGB 9343","author":"Hughes","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2021.08.018_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2016.01.020","article-title":"Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial","author":"Gentilini","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2021.08.018_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0042-122853","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: first results following commencement of the intergroup-sentinel-mamma (INSEMA) trial eingeschr\u00e4","volume":"77","author":"Reimer","year":"2017","journal-title":"Axillary Staging \u2026 Geburtsh Frauenheilk [Internet]"},{"key":"10.1016\/j.breast.2021.08.018_bib8","author":"Van Roozendaal"},{"issue":"1","key":"10.1016\/j.breast.2021.08.018_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-5053-7","article-title":"Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node","volume":"18","author":"Houvenaeghel","year":"2018","journal-title":"BMC Canc"},{"key":"10.1016\/j.breast.2021.08.018_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-020-05537-1","article-title":"The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer behalf of the SENOMAC Trialists' Group","volume":"180","author":"De Boniface","year":"2020","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2021.08.018_bib11","series-title":"POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015"},{"key":"10.1016\/j.breast.2021.08.018_bib12","doi-asserted-by":"crossref","unstructured":"Henke G, Knauer M, Ribi K, Hayoz S, G\u00e9rard M-A, Ruhstaller T, et\u00a0al. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial. Available from: https:\/\/doi.org\/10.1186\/s13063-018-3021-9.","DOI":"10.1186\/s13063-018-3021-9"},{"key":"10.1016\/j.breast.2021.08.018_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2021.08.018_bib14","article-title":"A\u00a0prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","author":"Kuemmel","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2021.08.018_bib15","doi-asserted-by":"crossref","unstructured":"Exner R, Exner FREBS. Post San Antonio Breast Cancer Symposium 2018 Local and operative therapy, radiotherapy. memo - Mag Eur Med Oncol [Internet]. Available from: https:\/\/doi.org\/10.1007\/s12254-019-0513-6.","DOI":"10.1007\/s12254-019-0513-6"},{"key":"10.1016\/j.breast.2021.08.018_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-018-5009-2","article-title":"Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?","author":"Hennigs","year":"2019","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2021.08.018_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002354","article-title":"Axillary dissection and nodal irradiation can Be avoided for most node-positive z0011-eligible breast cancers: a prospective validation study of 793 patients","author":"Morrow","year":"2017","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.breast.2021.08.018_bib18","first-page":"515","article-title":"Breast cancer breast cancer","volume":"70","author":"Macdonald","year":"2016","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.breast.2021.08.018_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000004356","article-title":"Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis","author":"Samiei","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2021.08.018_bib20","article-title":"Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer","author":"Wong","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2021.08.018_bib21","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","author":"Kahler-Ribeiro-Fontana","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2021.08.018_bib22","first-page":"527","volume":"vol. 186","author":"Damin","year":"2021"},{"key":"10.1016\/j.breast.2021.08.018_bib23","doi-asserted-by":"crossref","unstructured":"Piltin MA, Hoskin TL, Day CN, Davis J, Boughey JC. Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer. Available from: https:\/\/doi.org\/10.1245\/s10434-020-08900-0.","DOI":"10.1245\/s10434-020-08900-0"},{"key":"10.1016\/j.breast.2021.08.018_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1245\/s10434-020-08928-2","article-title":"Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual N1 nodal disease following neoadjuvant chemotherapy","volume":"28","author":"Almahariq","year":"2021","journal-title":"Ann Surg Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977621004471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977621004471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:43:47Z","timestamp":1760777027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977621004471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"alternative-id":["S0960977621004471"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2021.08.018","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axillary surgery in node-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2021.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}